2015 Advances in Inflammatory Bowel Diseases
AIBD 2015 will "cover all of the important approaches to both the basic and the advanced care of the IBD patient, as well as recent advances in cutting edge clinical research." The meeting's in-depth workshops, presentations, and other sessions are designed to meet the educational needs of healthcare professionals involved in the treatment of pediatric and adult patients with inflammatory bowel diseases.
Measures in place to limit systemic steroid use for patients with inflammatory bowel disease are not as effective as they need to be. They should be replaced by a two-part model to examine drug utilization patterns that would separately consider factors associated with initiation and duration of therapy.
Patients with Ulcerative Colitis Who Receive a Stem Cell Transplant Are at Higher Risk for Deadly Opportunistic Infections
Assessing the Effect of Vitamin D Insufficiency in African American Patients with Inflammatory Bowel Disease
Russell Cohen, MD, director of the Inflammatory Bowel Diseases Center at The University of Chicago Medicine, discussed the progress made not only in the clinical care of IBD, but also in the basic science group and translational core at the 2015 Advances in Inflammatory Bowel Diseases meeting in Orlando, FL.